Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively by Carol Moreno, Cecilia Muñoz, María José Terol, José-Ángel Hernández-Rivas, Miguel Villanueva

Get full text

The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies by José-Ángel Hernández-Rivas, Rafael Ríos-Tamayo, Cristina Encinas, Rafael Alonso, Juan-José Lahuerta

Get full text

Challenging Diagnosis of Invasive Sinus Aspergillosis Mimicking Gradenigo’s Syndrome in an Elderly Patient with T-Cell Lymphoma by Victoria Ramos de Ascanio, Gloria Liaño-Esteso, David Roldán, Teresa Collazo-Lorduy, Sara Martínez-Flores, José Ángel Hernández-Rivas, Isabel González-Gascón-y-Marín

Get full text

Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up by Martin Dreyling, Andre Goy, Georg Hess, Brad S. Kahl, José-Ángel Hernández-Rivas, Natasha Schuier, Keqin Qi, Sanjay Deshpande, Angeline Zhu, Lori Parisi, Michael L. Wang

Get full text

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment by Claudia Pérez-Carretero, Isabel González-Gascón-y-Marín, Ana E. Rodríguez-Vicente, Miguel Quijada-Álamo, José-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas

Get full text

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct by Isabel González-Gascón-y-Marín, Carolina Muñoz-Novas, Ana-Eugenia Rodríguez-Vicente, Miguel Quijada-Álamo, María Hernández-Sánchez, Claudia Pérez-Carretero, Victoria Ramos-Ascanio, José-Ángel Hernández-Rivas

Get full text

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When by Isabel González-Gascón-y-Marín, Mónica Ballesteros-Andrés, Sara Martínez-Flores, Ana-E Rodríguez-Vicente, Claudia Pérez-Carretero, Miguel Quijada-Álamo, Alberto Rodríguez-Sánchez, José-Ángel Hernández-Rivas

Get full text

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study by Javier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, José Ángel Hernández-Rivas, Rafael Andreu-Lapiedra, Alba Mora, Carolina Leiva-Farré, María Dolores López-Roda, Ángel Callejo-Mellén, Esther Álvarez-García, José Antonio García-Marco

Get full text

PB2687: DIGITAL-HEALTH AND REMOTE MONITORING FOR PATIENTS RECEIVING AZACITIDINE AT HOME. A FURTHER STEP TOWARDS HUMANIZATION AND PATIENT-CENTERED MEDICINE by Isabel Gonzalez-Gascon-Y-Marin, María Mir, Alejandro Santiago, Maria Angeles Foncillas Garcia, Teresa Osorio, Francisco-José Ruiz-Gómez, Maria José Solaeta, Victorino Diez, Nuria Suarez-Liceras, Carlos Bibiano-Guillén, Jose Ángel Hernández Rivas

Get full text

PB2293: REAL WORLD STUDY OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE ELDERLY: FOURTEEN YEARS OF ONE CENTER’S EXPERIENCE by Victoria Ramos De Ascanio, Alejandro Sanchez Salto, Juan Churruca, Maria Angeles Foncillas Garcia, Isabel González Gascón Y Marín, Elena Landete, Carolina Muñoz Novas, Laura Sanchez Paz, Karen Marin Mori, Jose Ángel Hernández Rivas, Maria Stefania Infante

Get full text

Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine by Elena Landete, Isabel Gómez-Fernández, Isabel González-Gascón-y-Marín, Carmen Durán-Barquero, Juan Churruca, María-Stefania Infante, Carolina Muñoz-Novas, María-Ángeles Foncillas, Karen Marín, Victoria Ramos-de-Ascanio, Juan Carlos Alonso-Farto, José-Ángel Hernández-Rivas

Get full text

Association of Cytogenetics Aberrations and <i>IGHV</i> Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting by Carolina Muñoz-Novas, Isabel González-Gascón-y-Marín, Iñigo Figueroa, Laura Sánchez-Paz, Claudia Pérez-Carretero, Miguel Quijada-Álamo, Ana-Eugenia Rodríguez-Vicente, María-Stefania Infante, María-Ángeles Foncillas, Elena Landete, Juan Churruca, Karen Marín, Victoria Ramos, Alejandro Sánchez Salto, José-Ángel Hernández-Rivas

Get full text

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression by Miguel Quijada-Álamo, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñón, José María Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús-María Hernández-Rivas

Get full text

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia by Miguel Quijada‐Álamo, Claudia Pérez‐Carretero, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente, Ana‐Belén Herrero, Jesús‐María Hernández‐Sánchez, Marta Martín‐Izquierdo, Sandra Santos‐Mínguez, Mónica del Rey, Teresa González, Araceli Rubio‐Martínez, Alfonso García de Coca, Julio Dávila‐Valls, José‐Ángel Hernández‐Rivas, Helen Parker, Jonathan C. Strefford, Rocío Benito, José‐Luis Ordóñez, Jesús‐María Hernández‐Rivas

Get full text

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Contro... by Nuria Muñoz-Rivas, Jesús Aibar, Cristina Gabara-Xancó, Ángela Trueba-Vicente, Ana Urbelz-Pérez, Vicente Gómez-Del Olmo, Pablo Demelo-Rodríguez, Alberto Rivera-Gallego, Pau Bosch-Nicolau, Montserrat Perez-Pinar, Mónica Rios-Prego, Olga Madridano-Cobo, Laura Ramos-Alonso, Jesús Alonso-Carrillo, Iria Francisco-Albelsa, Edelmira Martí-Saez, Ana Maestre-Peiró, Manuel Méndez-Bailón, José Ángel Hernández-Rivas, Juan Torres-Macho

Get full text

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study by Isabel Regalado-Artamendi, Ana Jiménez-Ubieto, José Ángel Hernández-Rivas, Belén Navarro, Lucía Núñez, Concha Alaez, Raúl Córdoba, Francisco Javier Peñalver, Jimena Cannata, Pablo Estival, Keina Quiroz-Cervantes, Rosalía Riaza Grau, Alberto Velasco, Rafael Martos, Amalia Domingo-González, Laurentino Benito-Parra, Elvira Gómez-Sanz, Javier López-Jiménez, Arturo Matilla, María Regina Herraez, María José Penalva, Julio García-Suárez, José Luis Díez-Martín, Mariana Bastos-Oreiro

Get full text

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients by José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, Irene García-Cadenas, Lourdes Vazquez, Javier Lopez-Jimenez, Pedro Chorão, Cristina Aroca, Carolina García-Vidal, Ignacio Arroyo, Eva Soler-Espejo, Lucia López-Corral, Alejandro Avendaño-Pita, Anna Arrufat, Valentín Garcia-Gutierrez, Elena Arellano, Lorena Hernández-Medina, Clara González-Santillana, Julia Morell, José Ángel Hernández-Rivas, Paula Rodriguez-Galvez, Mireia Mico-Cerdá, Manuel Guerreiro, Diana Campos, David Navarro, Ángel Cedillo, Rodrigo Martino, Carlos Solano

Get full text

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders by José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Lourdes Vazquez, Ariadna Pérez, Gabriel Martin-Martin, Beatriz Gago, Gabriela Sanz-Linares, Andrés Sanchez-Salinas, Lucia Villalon, Venancio Conesa-Garcia, María T. Olave, Magdalena Corona, Sara Marcos-Corrales, Mar Tormo, José Ángel Hernández-Rivas, Juan Montoro, Alicia Rodriguez-Fernandez, Irene Risco-Gálvez, Pablo Rodríguez-Belenguer, Juan Carlos Hernandez-Boluda, Irene García-Cadenas, Montserrat Ruiz-García, Juan Luis Muñoz-Bellido, Carlos Solano, Ángel Cedillo, Anna Sureda, David Navarro, the Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC)

Get full text

COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant by Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso, Víctor Jiménez Yuste, José María Aspa-Cilleruelo, Cristian Escolano Escobar, Javier López-Jiménez, Rafael Duarte, Cristina Jacome Yerovi, José-Ángel Hernández-Rivas, Regina Herráez, Keina Quiroz-Cervantes, Rosalía Bustelos-Rodriguez, Celina Benavente, Pilar Martínez Barranco, Mariana Bastos Oteiro, Adrián Alegre, Jaime Pérez-Oteyza, Elena Ruiz, Eriel Alexis Marcheco-Pupo, Ángel Cedillo, Teresa de Soto Álvarez, Patricia García Ramirez, Rosalía Alonso Trillo, Pilar Herrera, María Luisa Bengochea Casado, Andrés Arroyo Barea, Jose Manuel Martin De Bustamante, Javier Ortiz, María Calbacho Robles, Julio García-Suárez

Get full text

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients by José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, Gabriela Sanz-Linares, Venancio Conesa-Garcia, Andrés Sanchez-Salinas, Beatriz Gago, Ana Facal, Irene Risco-Gálvez, María T. Olave, Ildefonso Espigado, Javier Lopez-Jimenez, José Ángel Hernández-Rivas, Alejandro Avendaño-Pita, Ignacio Arroyo, Elena Ferrer, Irene García-Cadenas, Clara González-Santillana, Alicia Roldán-Pérez, Blanca Ferrer, Manuel Guerreiro, María Suarez-Lledó, Angela Camara, Diana Campos-Beltrán, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC), Rodrigo Martino

Get full text